Business Wire
27 May 2026, 11:47 UTC · 22w ago
Verdict
Headline takes no side. We score GH +0.80 across two claims — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
The American Cancer Society (ACS) has included Guardant Health's Shield blood test in its updated Colorectal Cancer Screening Guidelines.
More positive than 99% of claims this week
The ACS guidelines specifically recommend Shield for patients who decline or have not completed stool-based or visual examination tests.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 85% of claims this week
Which stocks this story touches
More positive than 87% of ticker scores this week
The company's Shield blood test was included in the updated American Cancer Society screening guidelines, increasing its clinical adoption.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
2h ago
—
No price for GH right now — the quote feed didn't answer.
GH chart →
